EUVIMEDEUVIMED entdecken
LeitlinieSystematische Übersicht

Screening for Skin Cancer

US Preventive Services Task Force, Carol M Mangione, Michael J Barry, Wanda K Nicholson, David Chelmow, Tumaini Rucker Coker, Esa M Davis, Katrina E Donahue, Carlos Roberto Jaén, Martha Kubik, Li Li, Gbenga Ogedegbe und 6 weitere

JAMA · 18.04.2023 · 329 (15) · 1290

DOI: 10.1001/jama.2023.4342 ↗

Kurz gefasst

Leitlinie in der Zeitschrift JAMA, erschienen am 18.04.2023. Verfasst von US Preventive Services Task Force und 17 weiteren Autor:innen. Beteiligte Einrichtung: University of California, Los Angeles. Hauptthemen laut MEDLINE: Early Detection of Cancer, Mass Screening, Melanoma, Skin Neoplasms. Die Arbeit wurde bisher 116-mal zitiert (Crossref) und nennt 28 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance Skin cancer is the most commonly diagnosed cancer in the US. There are different types of skin cancer varying in disease incidence and severity. Basal and squamous cell carcinomas are the most common types of skin cancer but infrequently lead to death or substantial morbidity. Melanomas represent about 1% of skin cancer and cause the most skin cancer deaths. Melanoma is about 30 times more common in White persons than in Black persons. However, persons with darker skin color are often diagnosed at later stages, when skin cancer is more difficult to treat. Objective To update its 2016 recommendation, the US Preventive Services Task Force (USPSTF) commissioned a systematic review on the benefits and harms of screening for skin cancer in asymptomatic adolescents and adults. Population Asymptomatic adolescents and adults who do not have a history of premalignant or malignant skin lesions. Evidence Assessment The USPSTF concludes that the evidence is insufficient to determine the balance of benefits and harms of visual skin examination by a clinician to screen for skin cancer in asymptomatic adolescents and adults. Recommendation The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of visual skin examination by a clinician to screen for skin cancer in adolescents and adults. (I statement)

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Early Detection of CancerMass ScreeningMelanomaSkin NeoplasmsBasal Cell CarcinomaCarcinoma, Squamous CellAdolescentAdultHumansPhysical ExaminationRisk Assessment

Autor:innen und Institutionen

  • University of California, Los Angeles.
  • Harvard Medical School, Boston, Massachusetts.
  • George Washington University, Washington, DC.
  • Virginia Commonwealth University, Richmond.
  • University of Washington, Seattle.
  • University of Pittsburgh, Pittsburgh, Pennsylvania.

Zitieren

APA

US Preventive Services Task Force, Mangione, C. M., Barry, M. J., Nicholson, W. K., Chelmow, D., Coker, T. R., Davis, E. M., Donahue, K. E., Jaén, C. R., Kubik, M., Li, L., Ogedegbe, G., Rao, G., Ruiz, J. M., Stevermer, J., Tsevat, J., Underwood, S. M., & Wong, J. B. (2023). Screening for Skin Cancer. JAMA, 329(15), 1290. https://doi.org/10.1001/jama.2023.4342

Vancouver

US Preventive Services Task Force, Mangione CM, Barry MJ, Nicholson WK, Chelmow D, Coker TR, et al. Screening for Skin Cancer. JAMA. 2023;329(15):1290. doi:10.1001/jama.2023.4342

BibTeX
@article{USPreventiveServicesTaskForce2023,
  author = {US Preventive Services Task Force, US Preventive Services Task Force and Mangione, Carol M and Barry, Michael J and Nicholson, Wanda K and Chelmow, David and Coker, Tumaini Rucker and Davis, Esa M and Donahue, Katrina E and Jaén, Carlos Roberto and Kubik, Martha and Li, Li and Ogedegbe, Gbenga and Rao, Goutham and Ruiz, John M and Stevermer, James and Tsevat, Joel and Underwood, Sandra Millon and Wong, John B},
  title = {Screening for Skin Cancer},
  journal = {JAMA},
  year = {2023},
  volume = {329},
  number = {15},
  pages = {1290},
  doi = {10.1001/jama.2023.4342}
}
Kostenlos starten →